Stock Ticker

  • Loading stock data...

Heat Biologics Inc (NASDAQ:HTBX) Appoints Dr. Jeff Hutchins As New Chief Operating Officer

Heat Biologics Inc (NASDAQ:HTBX) has appointed Dr. Jeff Hutchins as its Chief Operating Officer. Dr. Hutchins was previously CSO and SVP, Pre-clinical Development with the company. In his new role, he will lead product development initiatives for Heat Biologic and its Pelican Therapeutics subsidiary firm. The management view Jeff Wolf, the CEO of Heat Biologics, […]

Peregrine Pharmaceuticals (NASDAQ:PPHM): Up With Their Inventions

Boston, MA 04/08/2014 (wallstreetpr) – Peregrine Pharmaceuticals (NASDAQ:PPHM) has introduced monoclonal antibodies for the diagnosis and treatment of cancerous cells present in the body. The U.S. based bio pharmaceutical company has reported that this very invention will help in opening a new horizon in the medical science. Announcement of the 3-abstracts of the company: The company […]

Investor Alert: Marani Brands, Inc. (OTCMKTS:MRIB), ProTek Capital Inc (OTCMKTS:PRPM), Peregrine Pharmaceuticals (NASDAQ:PPHM)

Boston, MA 03/13/2014 (wallstreetpr) – Marani Brands, Inc. (OTCMKTS:MRIB) management recently took to a video interview announcing to investors the company had received a verbal approval  for a license for an alcohol distribution in California. Although the California department concerned with such approvals still lists the license approval of the business as pending, MRIB CEO […]

Shareholder Breakfast: Scorpio Bulkers Inc (NYSE:SALT), Peregrine Pharmaceuticals (NASDAQ:PPHM), Guanwei Recycling Corp. (NASDAQ:GPRC)

Boston, MA 03/10/2014 (wallstreetpr) – Scorpio Bulkers Inc (NYSE:SALT) shares had their price target lifted by analysts at Evercore Partners to $15 from $14. The new price target on the stock suggests possible upside of more than 52 percent if attained from the current price. Shares traded up 3.25 percent to $10.16 in Friday session. […]

Peregrine Pharmaceuticals (NASDAQ:PPHM) Sustainable?

Boston, MA 03/06/2014 (wallstreetpr) – Peregrine Pharmaceuticals (NASDAQ:PPHM) was able to achieve a strong gain where the share prices soared more than 50 percent on Wednesday. But on Thursday the stock was in some kind of correction, last seen down more than 5 percent, despite hitting a new 12-month high of $3.18 in the early trading. […]

Sign Up To Get Our Latest Stocks Alerts